Wong, Raymond S
Chinese University of Hong Kong · Prince of Wales Hospital
2 papers on CoChatORCID 0000-0002-9011-4268
Most cited papers
- Verified
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
van Rhee, F., Wong, R. S., Munshi, N., Rossi, J.-F., Ke, X.-Y., Fosså, A., Simpson, D., Capra, M., Liu, T., Hsieh, R. K., et al. (2014) · The Lancet Oncology
Viral-associated cancers and disordersLymphadenopathy Diagnosis and Analysis
Cited by 454
- Verified
Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (Anti-IL6 Monoclonal Antibody) in patients with multicentric castleman disease
Casper, C., Chaturvedi, S., Munshi, N., Wong, R., Qi, M., Schaffer, M., Bandekar, R., Hall, B., van de Velde, H., Vermeulen, J., et al. (2015) · Clinical Cancer Research
Viral-associated cancers and disordersAutoimmune and Inflammatory Disorders Research
Cited by 97
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free